We are proud to be at the forefront of funding innovative research into gene therapy treatments

A study into the impact of severe covid-19 infection on patients who receive stem cell transplants for blood cancers and blood disorders.

Leukaemia UK is delighted to announce that we are funding more ground-breaking research in 2023, by continuing our investment in early career scientists and clinicians for our prestigious John Goldman…

Former Leukaemia UK John Goldman Fellows, Dr Matthew Blunt, University of Southampton and Dr Konstantinos Tzelepis, University of Cambridge have been recognised as ‘Emerging Leaders in Leukaemia’ by the major…